Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Monitor legislation related to Medicare and other health care issues and advise client. Monitor and advise re Food Safety Enhancement Act of 2009 and Food Safety Modernization Act (S510). Implementation of PPACA
Patent Reform Act of 2009 (HR 1260/S515/S610).
HR 4213, American Jobs and Closing Tax Loopholes Act.
Duration: November 1, 2007
to
June 30, 2010
General Issues: Medicare/Medicaid , Health Issues , Copyright/Patent/Trademark , Taxation/Internal Revenue Code , Defense
Spending: about $460,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate, U.S. Senate,, Health & Human Services - Dept of (HHS), White House Office, Executive Office of the President (EOP), Commerce - Dept of (DOC), White House Office,, Y
Y
House of Representatives
Senate
Human Resources and Services
White House
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
DUTKO WORLDWIDE, LLC terminated an engagement in which they represented ABBOTT LABORATORIES on July 14, 2010.
Original Filing: 300286272.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor legislation related to Medicare and other health care issues and advise client. Monitor and advise re Food Safety Enhancement Act of 2009 and Food Safety Modernization Act (S510). Implementation of PPACA
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Patent Reform Act of 2009 (HR 1260/S515/S610).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
HR 4213, American Jobs and Closing Tax Loopholes Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $50,000. The report was filed on April 5, 2010.
Original Filing: 300254462.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),
Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal legislation related to health care IT issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),
Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2009
In Q4, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $30,000. The report was filed on Dec. 31, 2009.
Original Filing: 300226951.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),
Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),
Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal legislation related to Medicare and other health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),
Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2009
In Q3, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $30,000. The report was filed on Oct. 1, 2009.
Original Filing: 300199849.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Also monitored: America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Also: America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2009
In Q2, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $30,000. The report was filed on July 9, 2009.
Original Filing: 300173771.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced) Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced)Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal legislation related to health-care trade secrets/patents and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced)Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
In Q1, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $30,000. The report was filed on April 8, 2009.
Original Filing: 300144845.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2008
In Q4, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $60,000. The report was filed on Jan. 2, 2009.
Original Filing: 300113189.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Executive Office of the President (EOP)
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Monitor federal legislation related to copyright, patent and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Commerce - Dept of (DOC) White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Medicare and other health care-related issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
3rd Quarter, 2008
In Q3, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $60,000. The report was filed on Oct. 6, 2008.
Original Filing: 300088095.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Executive Office of the President (EOP)
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Monitor federal legislation related to health care patent issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Commerce - Dept of (DOC) White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
2nd Quarter, 2008
In Q2, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $60,000. The report was filed on July 2, 2008.
Original Filing: 300060814.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Executive Office of the President (EOP)
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331). Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Commerce - Dept of (DOC) White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United Sate Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331).Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
1st Quarter, 2008
DUTKO WORLDWIDE, LLC amended a lobbying report for representation of ABBOTT LABORATORIES in Q12008 on April 9, 2008.
Original Filing: 300034152.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
Lobbying Issues
Monitor federal legislation related to Patent Reform and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Commerce - Dept of (DOC)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare and other health care issues and advise client as it affects them. Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
1st Quarter, 2008
In Q1, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $60,000. The report was filed on April 3, 2008.
Original Filing: 300032214.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
Lobbying Issues
Monitor federal legislation related to Patent Reform and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Commerce - Dept of (DOC)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare and other health care issues and advise client as it affects them. Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
0th Quarter, 2007
In MM, DUTKO WORLDWIDE, LLC lobbied for ABBOTT LABORATORIES , earning $120,000. The report was filed on Aug. 3, 2007.
Original Filing: 200045679.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other healthcare issues and advise client as it affects them
Agencies Lobbied
Y
Y
House of Representatives
Senate
Human Resources and Services
White House
Lobbying Issues
Monitor federal legislation related to Medicare and other healthcare issues and advise clients as it affects them.
Agencies Lobbied
Y
Y
House of Representatives
Senate
Human Resources and Services
White House
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate